Efficacy and Safety of Different Dose of Tirofiban in Interventional Treatment of Complex Coronary Artery Disease
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate the efficacy and safety different dose of GPIIb/IIIa
inhibitor (tirofiban) in interventional treatment of complex coronary artery disease ,which
include bifurcation lesion, left main lesion, multiple vessel disease, intracoronary
thrombus, SYNTAX score>26,chronic total occlusion disease. The primary endpoint is all-cause
mortality. Secondary endpoints are incidence of major bleeding and the rate of site access
complication.